vs
REV Group, Inc.（REVG）与Royalty Pharma plc（RPRX）财务数据对比。点击上方公司名可切换其他公司
REV Group, Inc.的季度营收约是Royalty Pharma plc的1.1倍（$664.4M vs $622.0M），Royalty Pharma plc净利率更高（34.4% vs 4.3%，领先30.1%），REV Group, Inc.同比增速更快（11.1% vs 4.8%），过去两年REV Group, Inc.的营收复合增速更高（6.5% vs 4.6%）
REV Group是一家美国智能语音转文字服务提供商，总部位于旧金山和奥斯汀，成立于2010年，核心业务涵盖隐藏字幕制作、多语言字幕翻译及文字转录服务，曾获《PC Magazine》2018年编辑选择奖，2019年获评该杂志最佳转录服务提供商。
本公司是总部位于美国马萨诸塞州剑桥市的临床阶段生物制药企业，专注于研发可调节转化生长因子β（TGF-β）超家族蛋白的药物，该类蛋白在红细胞、肌肉、骨骼、血管等细胞与组织的生长修复过程中发挥核心作用。
REVG vs RPRX — 直观对比
营收规模更大
REVG
是对方的1.1倍
$622.0M
营收增速更快
REVG
高出6.3%
4.8%
净利率更高
RPRX
高出30.1%
4.3%
两年增速更快
REVG
近两年复合增速
4.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $664.4M | $622.0M |
| 净利润 | $28.9M | $214.2M |
| 毛利率 | 15.4% | — |
| 营业利润率 | 7.1% | 62.4% |
| 净利率 | 4.3% | 34.4% |
| 营收同比 | 11.1% | 4.8% |
| 净利润同比 | -30.7% | 2.9% |
| 每股收益（稀释后） | $0.57 | $0.49 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收REVGRPRX
| Q4 25 | $664.4M | $622.0M | ||
| Q3 25 | $644.9M | $609.3M | ||
| Q2 25 | $629.1M | $578.7M | ||
| Q1 25 | $525.1M | $568.2M | ||
| Q4 24 | $597.9M | $593.6M | ||
| Q3 24 | $579.4M | $564.7M | ||
| Q2 24 | $616.9M | $537.3M | ||
| Q1 24 | $586.0M | $568.0M |
净利润REVGRPRX
| Q4 25 | $28.9M | $214.2M | ||
| Q3 25 | $29.1M | $288.2M | ||
| Q2 25 | $19.0M | $30.2M | ||
| Q1 25 | $18.2M | $238.3M | ||
| Q4 24 | $41.7M | $208.2M | ||
| Q3 24 | $18.0M | $544.0M | ||
| Q2 24 | $15.2M | $102.0M | ||
| Q1 24 | $182.7M | $4.8M |
毛利率REVGRPRX
| Q4 25 | 15.4% | — | ||
| Q3 25 | 15.8% | — | ||
| Q2 25 | 15.2% | — | ||
| Q1 25 | 13.3% | — | ||
| Q4 24 | 13.2% | — | ||
| Q3 24 | 13.5% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 10.7% | — |
营业利润率REVGRPRX
| Q4 25 | 7.1% | 62.4% | ||
| Q3 25 | 8.8% | 70.1% | ||
| Q2 25 | 7.9% | 36.3% | ||
| Q1 25 | 5.3% | 94.0% | ||
| Q4 24 | 5.8% | 60.9% | ||
| Q3 24 | 4.9% | — | ||
| Q2 24 | 3.7% | 50.2% | ||
| Q1 24 | -1.1% | -13.0% |
净利率REVGRPRX
| Q4 25 | 4.3% | 34.4% | ||
| Q3 25 | 4.5% | 47.3% | ||
| Q2 25 | 3.0% | 5.2% | ||
| Q1 25 | 3.5% | 41.9% | ||
| Q4 24 | 7.0% | 35.1% | ||
| Q3 24 | 3.1% | 96.3% | ||
| Q2 24 | 2.5% | 19.0% | ||
| Q1 24 | 31.2% | 0.8% |
每股收益（稀释后）REVGRPRX
| Q4 25 | $0.57 | $0.49 | ||
| Q3 25 | $0.59 | $0.67 | ||
| Q2 25 | $0.38 | $0.07 | ||
| Q1 25 | $0.35 | $0.55 | ||
| Q4 24 | $1.03 | $0.46 | ||
| Q3 24 | $0.35 | $1.21 | ||
| Q2 24 | $0.28 | $0.23 | ||
| Q1 24 | $3.06 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $34.7M | $618.7M |
| 总债务越低越好 | — | $9.0B |
| 股东权益账面价值 | $416.3M | $9.7B |
| 总资产 | $1.2B | $19.6B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资REVGRPRX
| Q4 25 | $34.7M | $618.7M | ||
| Q3 25 | $36.0M | $938.9M | ||
| Q2 25 | $28.8M | $631.9M | ||
| Q1 25 | $31.6M | $1.1B | ||
| Q4 24 | $24.6M | $929.0M | ||
| Q3 24 | $50.5M | $950.1M | ||
| Q2 24 | $38.2M | $1.8B | ||
| Q1 24 | $87.9M | $843.0M |
总债务REVGRPRX
| Q4 25 | — | $9.0B | ||
| Q3 25 | — | $8.9B | ||
| Q2 25 | — | $8.0B | ||
| Q1 25 | — | $7.6B | ||
| Q4 24 | — | $7.6B | ||
| Q3 24 | — | $7.6B | ||
| Q2 24 | — | $7.6B | ||
| Q1 24 | — | $6.1B |
股东权益REVGRPRX
| Q4 25 | $416.3M | $9.7B | ||
| Q3 25 | $387.3M | $9.6B | ||
| Q2 25 | $357.8M | $9.5B | ||
| Q1 25 | $428.8M | $9.8B | ||
| Q4 24 | $435.1M | $10.3B | ||
| Q3 24 | $394.6M | $10.3B | ||
| Q2 24 | $379.7M | $9.8B | ||
| Q1 24 | $496.1M | $9.9B |
总资产REVGRPRX
| Q4 25 | $1.2B | $19.6B | ||
| Q3 25 | $1.2B | $19.3B | ||
| Q2 25 | $1.2B | $18.3B | ||
| Q1 25 | $1.2B | $17.6B | ||
| Q4 24 | $1.2B | $18.2B | ||
| Q3 24 | $1.3B | $18.0B | ||
| Q2 24 | $1.3B | $17.7B | ||
| Q1 24 | $1.4B | $16.1B |
负债/权益比REVGRPRX
| Q4 25 | — | 0.92× | ||
| Q3 25 | — | 0.93× | ||
| Q2 25 | — | 0.84× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.78× | ||
| Q1 24 | — | 0.62× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $76.9M | $827.1M |
| 自由现金流经营现金流 - 资本支出 | $53.7M | — |
| 自由现金流率自由现金流/营收 | 8.1% | — |
| 资本支出强度资本支出/营收 | 3.5% | — |
| 现金转化率经营现金流/净利润 | 2.66× | 3.86× |
| 过去12个月自由现金流最近4个季度 | $190.0M | — |
8季度趋势，按日历期对齐
经营现金流REVGRPRX
| Q4 25 | $76.9M | $827.1M | ||
| Q3 25 | $60.3M | $702.6M | ||
| Q2 25 | $117.0M | $364.0M | ||
| Q1 25 | $-13.1M | $596.1M | ||
| Q4 24 | $68.6M | $742.5M | ||
| Q3 24 | $14.4M | $703.6M | ||
| Q2 24 | $40.1M | $658.2M | ||
| Q1 24 | $-69.7M | $664.6M |
自由现金流REVGRPRX
| Q4 25 | $53.7M | — | ||
| Q3 25 | $48.7M | — | ||
| Q2 25 | $105.6M | — | ||
| Q1 25 | $-18.0M | — | ||
| Q4 24 | $63.3M | — | ||
| Q3 24 | $8.5M | — | ||
| Q2 24 | $34.2M | — | ||
| Q1 24 | $-80.2M | — |
自由现金流率REVGRPRX
| Q4 25 | 8.1% | — | ||
| Q3 25 | 7.6% | — | ||
| Q2 25 | 16.8% | — | ||
| Q1 25 | -3.4% | — | ||
| Q4 24 | 10.6% | — | ||
| Q3 24 | 1.5% | — | ||
| Q2 24 | 5.5% | — | ||
| Q1 24 | -13.7% | — |
资本支出强度REVGRPRX
| Q4 25 | 3.5% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.8% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.9% | — | ||
| Q3 24 | 1.0% | — | ||
| Q2 24 | 1.0% | — | ||
| Q1 24 | 1.8% | — |
现金转化率REVGRPRX
| Q4 25 | 2.66× | 3.86× | ||
| Q3 25 | 2.07× | 2.44× | ||
| Q2 25 | 6.16× | 12.06× | ||
| Q1 25 | -0.72× | 2.50× | ||
| Q4 24 | 1.65× | 3.57× | ||
| Q3 24 | 0.80× | 1.29× | ||
| Q2 24 | 2.64× | 6.45× | ||
| Q1 24 | -0.38× | 139.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
REVG
| Specialty Vehicles | $507.4M | 76% |
| Recreational Vehicles | $157.2M | 24% |
RPRX
| Financial Royalty Assets | $592.4M | 95% |
| Royalty Income Other | $29.6M | 5% |
